Delivery Order SPE2DB22D3016-SPE2DB25FBJP3
- Not listed
- The Defense Logistics Agency awarded a $1,917.24 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Adderall XR 10 mg capsules (100-count units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 17, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) with a contract ceiling value of $1,686.07. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a competitively awarded, non-set-aside procurement. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a $1,997.24 delivery order to AmerisourceBergen Drug Corp for Adderall XR 10 mg capsules (100-count units) on August 4, 2025, with completion targeted for August 5, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, serves as a major...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) with a ceiling value of $2,096.64. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of October 17, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) valued at $1,721.09. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competitive procurement. The contract's place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- The Defense Logistics Agency awarded a $2,070.64 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Adderall XR 10 mg on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical federal healthcare vendor that...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Adderall XR 30 mg capsules (100-count units) valued at $2,984.62. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $1,142.47 to AmerisourceBergen Drug Corp for Adderall XR 30 mg capsules (quantity: 100s) on September 8, 2025, with completion scheduled for September 9, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location in the same city....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Adderall XR 10 mg capsules (100 count) with a ceiling value of $1,990.20. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and is scheduled for completion by September 15, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical...
- The Defense Logistics Agency awarded a $2,308.08 delivery order contract to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Adderall XR 10 mg capsules (100-count units). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 18, 2025, and performance based in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's military...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBJP3Delivery Order
The Defense Logistics Agency awarded a $1,709.51 delivery order to AmerisourceBergen Drug Corp for Adderall XR 10 mg capsules (100 count) on September 16, 2025, with completion scheduled for September 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.99 billion ceiling value through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates extensive capability in fulfilling pharmaceutical procurement requirements across multiple therapeutic domains, with consistent awards through open competitive processes, positioning it as a critical vendor for Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/16/25 |